EFFECT OF THROMBOPOIETIN RECEPTOR AGONISTS ON COAGULATION AND PLATELET ACTIVATION IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA

被引：0
|
作者：
Garabet, L. [1 ]
Lee, S. [2 ]
Mowinckel, M. -C. [3 ,4 ]
Jonassen, C. [1 ]
Liebman, H. [5 ]
Bussel, J. [2 ]
Sandset, P. M. [3 ,4 ,6 ]
Ghanima, W. [7 ]
机构：
[1] Ostfold Hosp Trust, Cenetre Lab Med, Fredrikstad, Norway
[2] Weill Cornell Med Coll, Dept Pediat, Unit Platelet Disorders, New York, NY USA
[3] Univ Hosp, Internal Med Res Inst, Oslo, Norway
[4] Univ Hosp, Dept Hematol, Oslo, Norway
[5] Norris Canc Hosp & Res Inst, Dept Med, Los Angeles, CA USA
[6] Univ Hosp, Inst Clin Med, Oslo, Norway
[7] Ostfold Hosp Trust, Dept Med, Fredrikstad, Norway
来源：
HAEMATOLOGICA | 2015年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
E1417
引用
收藏
页码：568 / 568
页数：1
相关论文
共 50 条
  • [31] Thrombopoietin receptor agonists in the treatment of thrombocytopenia
    Newland, Adrian
    CURRENT OPINION IN HEMATOLOGY, 2009, 16 (05) : 357 - 364
  • [32] Effect of thrombopoietin-receptor agonists on circulating cytokine and chemokine levels in patients with primary immune thrombocytopenia (ITP)
    Gudbrandsdottir, Sif
    Ghanima, Waleed
    Nielsen, Claus H.
    Feng, Xingmin
    Hasselbalch, Hans C.
    Bussel, James
    PLATELETS, 2017, 28 (05) : 478 - 483
  • [33] EFFECT OF THROMBOPOIETIN-RECEPTOR AGONISTS ON CIRCULATING CYTOKINE AND CHEMOKINE LEVELS IN PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA (ITP)
    Gudbrandsdottir, S.
    Ghanima, W.
    Feng, X.
    Lee, S.
    Nielsen, C.
    Hasselbalch, H.
    Bussel, J.
    HAEMATOLOGICA, 2012, 97 : 199 - 200
  • [34] Thrombopoietin receptor agonists in the treatment of immune thrombocytopenia: A clinician's perspective
    Ruggeri, Marco
    AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 (10) : 946 - 947
  • [35] Treatment of Immune Thrombocytopenia in Adults: The Role of Thrombopoietin-Receptor Agonists
    Rodeghiero, Francesco
    Ruggeri, Marco
    SEMINARS IN HEMATOLOGY, 2015, 52 (01) : 16 - 24
  • [36] EFFICACY AND SAFETY OF THROMBOPOIETIN RECEPTOR AGONISTS IN MODERN TREATMENT OF IMMUNE THROMBOCYTOPENIA
    Parvu, Andrada
    Orasan, Olga Hilda
    Pop, Stefan Vlad
    Zsoldos, Iulia Andrea
    Catana, Cristina
    Deac, Ioana Stefania
    Bojan, Anca Simona
    FARMACIA, 2021, 69 (02) : 219 - 230
  • [37] Thrombopoietin Receptor Agonists in Children with Immune Thrombocytopenia: A New Therapeutic Era
    Lassandro, Giuseppe
    Palladino, Valentina
    Vecchio, Giovanni C. D.
    Palmieri, Viviana V.
    Corallo, Paola C.
    Faienza, Maria F.
    Giordano, Paola
    ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2021, 21 (03) : 397 - 406
  • [38] Management of immune thrombocytopenia in France before the era of thrombopoietin receptor agonists
    Michel, M.
    Doz, M.
    Leclerc-Teffahi, S.
    Detournay, B.
    Levy-Bachelot, L.
    REVUE DE MEDECINE INTERNE, 2012, 33 (06): : 305 - 310
  • [39] Sustained remissions of immune thrombocytopenia associated with the use of thrombopoietin receptor agonists
    Ghadaki, Bahareh
    Nazi, Ishac
    Kelton, John G.
    Arnold, Donald M.
    TRANSFUSION, 2013, 53 (11) : 2807 - 2812
  • [40] A decision framework for treating chronic immune thrombocytopenia with thrombopoietin receptor agonists
    Dolph, Mike
    Roy, Anuja
    Bhor, Menaka
    Hearnden, Jaclyn
    Kwon, Christina S.
    Forsythe, Anna
    Tremblay, Gabriel
    Briggs, Andrew
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2018, 7 (08) : 775 - 784
12345